Nudges for Statin Prescribing in Primary Care
Nudges for Statin Prescribing in Primary Care
The objective of the study is to evaluate the effect of nudges to clinicians, patients, or
 both to initiate statin prescriptions for patients that meet national guidelines.
Cardiovascular disease (CVD) is the leading cause of mortality in the United States. Statins
 have been demonstrated to be an effective tool for reducing the risk of CVD-related events
 and mortality, but statins are often not prescribed for patients that meet evidence-based
 guidelines. In this study, the investigators will evaluate nudges to clinicians, patients, or
 both to initiate statin prescriptions for patients that meet the United States Preventive
 Task Force guidelines, patients with clinical atherosclerotic cardiovascular disease (ASCVD)
 condition, and patients with a history of familial hyperlipidemia. In partnership with the
 health system, this will be conducted as a 4-arm factorial, cluster randomized trial to
 evaluate the effect of the interventions.
Inclusion Criteria:

 1. Have new or return visit with a primary care provider at one of the study practices at
 the University of Pennsylvania Health System

 2. Either have an ASCVD condition, history of familial hyperlipidemia, or meet United
 State Preventive Task Force Guidelines for Statin Therapy which includes age 40-75
 years, at least 1 cardiovascular risk factor (e.g. dyslipidemia, diabetes,
 hypertension, smoking), 10-year ASVCD risk score ≥ 10%

 Exclusion Criteria:

 1. Already prescribed a statin

 2. Allergy to statins

 3. Severe renal insufficiency defined as glomerular filtration rate (GFR) less than 30
 mL/min or on dialysis

 4. Adverse reaction to statins including statin-related a) myopathy; b) Rhabdomyolysis;
 c) hepatitis

 5. Pregnant

 6. Currently breastfeeding

 7. on hospice or at the end-of-life

 8. On a PCSK9 Inhibitor medication

 Clinicians (and their respective patients) will be excluded if they have less than 10
 patients among their entire panel that are eligible for a statin medication.